Pausa pranzo con poster - SocietÃ italiana di neurologia

More documents

Recommendations

Info

9OTTOBRE•AREAPOSTER641. DECREASED CIRCULATING MIRNAS IN PATIENTS WITH MULTIPLESCLEROSISC. FENOGLIO, E. RIDOLFI, C. CANTONI, M. DE RIZ, A. PIETROBONI, M. SERPENTE,C. VILLA, R. BONSI, A. CALVI, L. PICCIO, A. CROSS, N. BRESOLIN, D. GALIMBERTI,E. SCARPINI (Milano, St. Louis - USA)642. STUDY OF ASSOCIATION BETWEEN NEUROTROPIC POLYOMAVIRUSESAND NEUROLOGIC DISORDERS, INCLUDING MULTIPLE SCLEROSISM. TOGNON, F. MARTINI, E. MAZZONI, S. PIETROBON, I. CASETTA, E. FAINARDI,M.CASTELLAZZI, E. GRANIERI (Ferrara)643. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES.IDENTIFICATION OF CIRCULATING NONCLASSIC HUMAN LEUKOCYTEANTIGEN G (HLA-G) DIMER MOLECULES IN CEREBROSPINAL FLUIDSFROM MS STABLE PATIENTSR. RIZZO, D. BORTOLOTTI, A. ROTOLA, M. CASTELLAZZI, C. TAMBORINO, E. BALDI,M. TOLA, E. GRANIERI, O. BARICORDI, E. FAINARDI (Ferrara)644. THE TOXIC INFLUENCE OF ENVIRONMENTAL FACTORS IN MULTIPLESCLEROSIS:OBSERVATIONAL STUDY IN THE CAMPANIA REGIONG. LUS, A. SAGLIOCCHI, S. BONAVITA, G. ALFIERI, G. TEDESCHI (Napoli)645. DEMYELINATING DISORDERS AND HPV VACCINATION: A CASE REPORTA. PROTTI, V. PRONE, C. ERMINIO, C. BETTO, R. VACCARI, I. PICCOLO, G. VIGHI,E. AGOSTONI (Milano)646. CERULOPLASMIN AS A MARKER OF CHRONIC SYSTEMIC INFLAMMATIONIN RELAPSING-REMITTING MULTIPLE SCLEROSISS. VOLLARO, D. LANDI, R. SQUITTI, A. CONIGLIO, D. LUPOI, A. GHAZARYAN, E.FALATO, M. CORBETTO, P. PASQUALETTI, F. VERNIERI, M. FILIPPI (Roma)647. FAVORABLE OUTCOME OF PML IN A SICILIAN MULTIPLE SCLEROSISPATIENT TREATED WITH NATALIZUMABS. BUCELLO, G. CALLARI, B. PALMERI, R. COSTA, G. VITELLO, L. GRIMALDI (Cefalù- PA)648. IMMUNOMODULATORY MECHANISMS OF NATALIZUMAB IN MULTIPLESCLEROSISM. RUGGIERI, P. IAFFALDANO, M. MASTRAPASQUA, D. PAOLICELLI, M. TROJANO(Bari)649. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES.IDENTIFICATION OF SERUM MICRORNAS AS MARKERS OF DISEASEACTIVITY IN MULTIPLE SCLEROSISS. SABBIONI, E. MIOTTO, M. FERRACIN, E. FAINARDI, M. CASTELLAZZI, C. BASSI, B.ZAGATTI, M. GENTILE, L. CANIATTI, R. TOLA, M. NEGRINI, E. GRANIERI (Ferrara)650. CSF CYTOLOGY IN CLINICALLY ISOLATED SYNDROME MAY PREDICTPROGRESSION TO MULTIPLE SCLEROSISY. MOTUZOVA, F. GRANIERI, P. VALENTINO, A. SALA, G. AMADORE, A. BERTOLOTTO(Minsk - BY, Orbassano - TO)651. IMMUNO-METABOLIC ASSET OF HISTORICAL HIGH-DOSESUBCUTANEOUS IFNB-1A TREATED MULTIPLE SCLEROSIS PATIENTSF. CARBONE, A. PAOLILLO, S. MONTELLA, P. CARRIERI, G. MATARESE (Napoli, Roma,Salerno)652. PROTEOMIC AND RED-OX PROTEOMIC ANALYSIS OF SERUM PROTEINSIN RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTST. KOUDRIAVTSEVA, E. ONESTI, E. BUCAJ, A. FIORINI, E. SBARDELLA, M. MINGOIA,F. DE MARCO, M. PERLUIGI (Roma)182
653. A ROLE FOR CELLULAR RESPONSE TO JC VIRUS IN NATALIZUMAB-TREATED PATIENTS? A LONGITUDINAL STUDY IN A NORTHERN ITALYPOPULATIONC. CHIAVAZZA, C. COSTA, S. MASERA, A. ROMAGNOLO, A. MATTIODA, F.DEMATTEIS, G. SUPERTI, F. VALLELONGA, L. PINESSI, L. LOPIANO, R. CAVALLO, P.CAVALLA (Torino)654. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLESE. GRANIERI, I. CASETTA, M. CASTELLAZZI, C. TAMBORINO, E. CESNIK, E. DELLACOLETTA, M. PADRONI, D. BENCIVELLI, F. PEDELINI, E. GROPPO, D. GUIDETTI, E.MONTANARI, F. GRANELLA, L. MOTTI, M. SANTANGELO, P. SOLA, G. SCANDELLARI,S. STECCHI, A. BALDRATI, F. SALVI, V. MUSSUTTO, L.CANIATTI, E. BALDI, R. TOLA,W. NERI, S. MALAGÙ, M. GALEOTTI, R. RAVASIO, S. GUTMANN, J. DRULOVIC, I.DUJMOVIC, V. KOSTIC (Ferrara, Piacenza, Fidenza - PR, Parma, Reggio Emilia, Carpi- MO, Modena, Bologna, Imola - BO, Forlì, Cesena, Ravenna Faenza Lugo - RA,Rimini, Repubblica <strong>di</strong> San Marino, Belgrado - SRB)655. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES.CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIAPNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSISC. CONTINI, S. SERACENI, M. MARITATI, M. CASTELLAZZI, C. TAMBORINO, E.BALDI, M. TOLA, E. GRANIERI, E. FAINARDI (Ferrara)656. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES.IDENTIFICATION OF A TIMP-1-RESISTANT ACTIVE MMP-9 IN SERUMOF MULTIPLE SCLEROSIS PATIENTSA. TRENTINI, T. BELLINI, M. MANFRINATO, F. DALLOCCHIO, E. BALDI, M. TOLA, M.CASTELLAZZI, C. TAMBORINO, E. GRANIERI, E. FAINARDI (Ferrara)657. ANTIPHOSPHOLIPID ANTIBODIES IN MULTIPLE SCLEROSIS:PATHOGENETIC OR EPIPHENOMENAL ROLE?T. KOUDRIAVTSEVA, P. CORDIALI-FEI, G. D’AGOSTO, E. ONESTI, E. SBARDELLA, E.TRENTO, F. ENSOLI (Roma)658. NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY TOPROSPECTIVELY EVALUATE SERUM-FREE SUBCUTANEOUS INTERFERONBETA-1A SAFETY AND TOLERABILITY IN THE TREATMENT OF NAIVERELAPSING MULTIPLE SCLEROSIS PATIENTS: PRELIMINARY RESULTSFROM THE STEP STUDYA. BERTOLOTTO, M. CALDANO, S. MALUCCHI, M. MALENTACCHI, S. COTTONE, P.SOLA, A. GHEZZI, C. SOLARO, S. STEP STUDY GROUP (Orbassano - TO, Palermo,Modena, Gallarate - VA, Genova, Italia)659. ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORKFOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERSOF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. THREEYEARS OF ACTIVITY OF REGISTRY. INCIDENCE STUDYE. GRANIERI, I. CASETTA, V. GOVONI, E. CESNIK, E. DELLA COLETTA, M.CASTELLAZZI, C. TAMBORINO, M. PADRONI, D. BENCIVELLI, E. GROPPO, F.PEDELINI, M. PASTORE, M. GENTILE, D. GUIDETTI, E. MONTANARI, F. GRANELLA,L. MOTTI, M. SANTANGELO, P. SOLA, G. SCANDELLARI, S. STECCHI, A. BALDRATI, F.SALVI, V. MUSSUTTO, R. TOLA, L. CANIATTI, W. NERI, S. MALAGÙ, M. GALEOTTI, F.RASI, R. RAVASIO, S. GUTMANN, C. MONALDINI (Ferrara, Piacenza, Parma, ReggioEmilia, Carpi - MO, Modena, Bologna, Imola - BO, Forlì, Cesena, Lugo - RA,Ravenna, Rimini, Repubblica <strong>di</strong> San Marino)9OTTOBRE•AREAPOSTER183
Page 1:
XLIII CONGRESSOSOCIETÀ ITALIANADI
Page 7 and 8:
Sotto l’Alto Patronatodella Presi
Page 9:
CONSIGLIO DIRETTIVO SINPresidente G
Page 12 and 13:
AREACONGRESSUALE
Page 15 and 16:
Programma scientifico
Page 17 and 18:
CORSO D’AGGIORNAMENTO A NUMERO CH
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29:
SIMPOSIOore 17.00 - 18.00NUOVE STRA
Page 32 and 33:
DOMENICA 7 OTTOBREAUDITORIUM SALA D
Page 34 and 35:
7OTTOBRE•SALADELLAPIAZZA1COMUNICA
Page 36 and 37:
7OTTOBRE•COMUNICAZIONI ORALI: SCL
Page 38 and 39:
7OTTOBRE•SALADELCASTELLOCOMUNICAZ
Page 40 and 41:
7OTTOBRE•SALADELTEMPIOCOMUNICAZIO
Page 42 and 43:
7OTTOBRE•SALADELL‘ARENGOCOMUNIC
Page 44 and 45:
7OTTOBRE•SALADELLAMARINACORSO DI
Page 46 and 47:
7OTTOBRE•SALASIMPOSIOore 13.30 -
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
7OTTOBRE•SALADELL‘ARCOSIMPOSIOo
Page 56 and 57:
7OTTOBRE•SIMPOSIOore 15.30 - 16.3
Page 58 and 59:
7OTTOBRE•SALADELLAWORKSHOPore 17.
Page 60 and 61:
7OTTOBRE•SALADELWORKSHOPore 17.00
Page 62 and 63:
7OTTOBRE•SALADELL‘ARCOWORKSHOPo
Page 64 and 65:
Page 66:
7OTTOBRE•SALAWORKSHOPore 17.00 -
Page 69 and 70:
SESSIONE PLENARIAore 08.00 - 09.30D
Page 71 and 72:
COMUNICAZIONI ORALI: SCLEROSI MULTI
Page 73 and 74:
COMUNICAZIONI ORALI: DEMENZA E INVE
Page 75 and 76:
COMUNICAZIONI ORALI: CASI CLINICI 2
Page 77 and 78:
COMUNICAZIONI ORALI: EPILESSIAore 1
Page 79 and 80:
COMUNICAZIONI ORALI: NEUROSCIENZE D
Page 81 and 82:
813.30-14.30ASSEMBLEA DEISOCI SINOT
Page 83 and 84:
SIMPOSIOore 14.30 - 15.30POLITERAPI
Page 85 and 86:
SIMPOSIOore 14.30 - 16.30MALATTIE N
Page 87 and 88:
SIMPOSIOore 15.30 - 16.30IL GENERE
Page 89 and 90:
LETTURAore 16.00 - 16.30PATTERN PRE
Page 91 and 92:
WORKSHOPore 17.00 - 19.00MONITORAGG
Page 93 and 94:
WORKSHOPore 17.00 - 19.00TREMORE ES
Page 95 and 96:
WORKSHOPore 17.00 - 19.00LA MORTE I
Page 98 and 99:
MARTEDI 9 OTTOBREAUDITORIUM SALA DE
Page 100 and 101:
9OTTOBRE•SALADELLAPIAZZACOMUNICAZ
Page 102 and 103:
9OTTOBRE•SALADELCASTELLO1COMUNICA
Page 104 and 105:
9OTTOBRE•SALADELTEMPIO1COMUNICAZI
Page 106 and 107:
9OTTOBRE•SALADELL‘ARCOCOMUNICAZ
Page 108 and 109:
9OTTOBRE•SALADELLAMARINACOMUNICAZ
Page 110 and 111:
9OTTOBRE•SALAINCONTROore 13.30 -
Page 112 and 113:
Page 114 and 115:
9OTTOBRE•LETTURAore 15.30 - 16.30
Page 116 and 117:
9OTTOBRE•SALAWORKSHOPore 17.00 -
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
9OTTOBRE•SALADELL‘ARENGOWORKSHO
Page 125 and 126:
CHIUSURA DEI LAVORI CONGRESSUALI18.
Page 127 and 128:
11. EPSTEIN-BARR VIRUS AS A TRIGGER
Page 129 and 130:
38. CLINICAL AND COGNITIVE CORRELAT
Page 131 and 132:
MALATTIE CEREBROVASCOLARI 1Moderato
Page 133 and 134: 85. STROKE UNIT IN THE “REAL WORD
Page 135 and 136: 106. SYMPTOMATIC STEROID INDUCED OS
Page 137 and 138: 125. CORRELATION BETWEEN SEXUAL DYS
Page 139 and 140: 146. MIGRAINE WITH AURA IN CHILDREN
Page 141 and 142: 168. DIFFERENT MOTOR NEURON IMPAIRM
Page 143 and 144: 187. CORRELATION BETWEEN NORTH STAR
Page 145 and 146: 210. DUAL SPIKE-TIMING-DEPENDENT PL
Page 147 and 148: 234. A RARE CAUSE OF CARPAL TUNNEL
Page 149 and 150: 255. SAFETY OF BEVACIZUMAB WITH OR
Page 151 and 152: POSTERore 12.00 - 13.30CASI CLINICI
Page 153 and 154: 297. INTRAMEDULLARY SPINAL CORD GLI
Page 155 and 156: 322. SEXUAL DYSFUNCTION IN PARKINSO
Page 157 and 158: 344. ADOPTING THE CLINICAL RISK MAN
Page 159 and 160: 364. SUBJECTIVE REPORTS ON THE EFFE
Page 161 and 162: 386. PRESENCE OF HEADACHE CORRELATE
Page 163 and 164: 410. BRAIN METABOLIC CORRELATES OF
Page 165 and 166: 432. A CLINICAL AND NEUROPHYSIOLOGI
Page 167 and 168: 456. PREVALENCE AND CLINICAL FEATUR
Page 169 and 170: 479. EXPLORING THE RELATIONSHIP BET
Page 171 and 172: NEUROPSICOLOGIA CLINICAModeratoriG.
Page 173 and 174: 527. THE EFFECT OF NATALIZUMAB ON C
Page 175 and 176: POSTERore 12.30 - 14.30CASI CLINICI
Page 177 and 178: 559. ISOLATED SPLENIAL LESION IN A
Page 179 and 180: 584. ALTERATIONS IN IRON CONTENT IN
Page 181 and 182: 607. EFFECT OF PRETREATMENT WITH ST
Page 183: 632. INTERNAL CAROTID ARTERY DISSEC
Page 187 and 188: 669. FREQUENCY OF DIFFERENT ETIOLOG
Page 189 and 190: 694. NECK FLEXION IN MRI AND SOMATO
Page 191 and 192: 716. CLINICAL AND GENETIC HETEROGEN
Page 193 and 194: 739. INFANTILE-ONSET HEREDITARY SPA
Page 195 and 196: 762. LACK OF ASSOCIATION BETWEEN NU
Page 197 and 198: 787. SUBACUTE PARANEOPLASTIC CEREBE
Page 199 and 200: 197
Page 201 and 202: PREMIAZIONE DEI MIGLIORI POSTEROgni
Page 203 and 204: Ai fini dell’ottenimento dei cred
Page 205: La Commissione Nazionale non ha sta
Page 208 and 209: SI RINGRAZIANO PER LA PARTECIPAZION
Page 210: Finito di stampare nel mese di sett
show all

Pausa pranzo con poster - SocietÃ italiana di neurologia

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?